Christopher D Ward - JoVE Visualize

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Filters

Christopher D Ward

Showing results (11-20 of 13) with videos related to

Pageof 2

Sort By:

You have reached the last page of results.This site can display upto 13 results.

Journal of Immunology (Baltimore, Md. : 1950)|October 9, 2002

BLyS and APRIL form biologically active heterotrimers that are expressed in patients with systemic immune-based rheumatic diseasesViktor Roschke, Svetlana Sosnovtseva, Christopher D Ward, et al.

Journal of Immunology (Baltimore, Md. : 1950)|November 20, 2008

In vivo BLyS/BAFF neutralization ameliorates islet-directed autoimmunity in nonobese diabetic miceGhazal Zekavat, Susan Y Rostami, Armen Badkerhanian, et al.

Transplantation|January 21, 2012

Murine islet allograft tolerance upon blockade of the B-lymphocyte stimulator, BLyS/BAFFRonald F Parsons, Ming Yu, Kumar Vivek, et al.

Pageof 2

Search research articles

Showing results (11-20 of 13) with videos related to

Sort By:

Pageof 2

You have reached the last page of results.This site can display upto 13 results.

Journal of Immunology (Baltimore, Md. : 1950)|October 9, 2002

BLyS and APRIL form biologically active heterotrimers that are expressed in patients with systemic immune-based rheumatic diseasesViktor Roschke, Svetlana Sosnovtseva, Christopher D Ward, et al.

Journal of Immunology (Baltimore, Md. : 1950)|November 20, 2008

In vivo BLyS/BAFF neutralization ameliorates islet-directed autoimmunity in nonobese diabetic miceGhazal Zekavat, Susan Y Rostami, Armen Badkerhanian, et al.

Transplantation|January 21, 2012

Murine islet allograft tolerance upon blockade of the B-lymphocyte stimulator, BLyS/BAFFRonald F Parsons, Ming Yu, Kumar Vivek, et al.

Pageof 2